A Review of Safety Data From Spontaneous Reports on Marketed Products Containing Tramadol and Celecoxib: A Vigibase Descriptive Analysis

Advances in Pharmacoepidemiology & Drug Safety
doi 10.4172/2167-1052.1000164
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Safety of Oral Nifuroxazide – Analysis of Data From a Spontaneous Reporting System

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

G190 Patient Safety Incidents in Neonatology: A 10-Year Descriptive Analysis of Reports From NHS England and Wales

2018English

Sensory Descriptive Evaluation of Food Products: A Review

Journal of Food Science and Nutrition Research
2019English

The Quality of Spontaneous Adverse Drug Reaction Reports in China: A Descriptive Study

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

The Effect of Food on Tramadol and Celecoxib Bioavailability Following Oral Administration of Co-Crystal of Tramadol–Celecoxib (CTC): A Randomised, Open-Label, Single-Dose, Crossover Study in Healthy Volunteers

Clinical Drug Investigation
MedicinePharmacology
2018English

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports

Drug Safety
ToxicologyPharmacology
2019English

Review of Extended-Release Formulations of Tramadol for the Management of Chronic Non-Cancer Pain: Focus on Marketed Formulations

Journal of Pain Research
AnesthesiologyPain Medicine
2014English

Olanzapine in Pregnancy and Breastfeeding: A Review of Data From Global Safety Surveillance

BMC pharmacology & toxicology
MedicinePharmacology
2013English

Exclusion of Elderly People From Clinical Research: A Descriptive Study of Published Reports

BMJ
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy